Authors




Katya Fonkych, PhD

Latest:

An Empirical Analysis of Hospital ED Pricing Power

We find that under current regulatory and market conditions, demand for hospital-based emergency services is highly inelastic with respect to price, giving hospitals substantial pricing power over out-of-network emergency services.



Cleo A. Samuel, BS

Latest:

Engaging Providers in Underserved Areas to Adopt Electronic Health Records

We assessed Regional Extension Centers' (RECs') progress in promoting EHR adoption among providers in rural and health professional shortage areas and found that RECs are achieving much success in enrolling these providers.



Ju-Young Shin, PhD

Latest:

Prescribing Trend of Pioglitazone After Safety Warning Release in Korea

The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.





Roberto Contreras, MD

Latest:

The Impact of Patient Assistance Programs and the 340B Drug Pricing Program on Medication Cost

Examining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.


Richard Snow, DO, MPH

Latest:

Racial Disparities in African Americans With Diabetes: Process and Outcome Mismatch

Racial disparities are widespread in healthcare. Disparities can have a strong influence on diabetes care. This manuscript explores the source of such disparities.





Yuze Yang, PharmD

Latest:

A Better Way: Leveraging a Proven and Utilized System for Improving Current Medication Reconciliation Processes

In this reply to the commentary, “A Call for a Statewide Medication Reconciliation Program,” published in the October 2016 issue of The American Journal of Managed Care®, authors discuss a proven and scalable solution to improve medication reconciliation that is already available to, and used by, clinicians.




Mayvis Rebeira, PhD

Latest:

Cost-effectiveness of Brentuximab Vedotin With Chemotherapy in Treatment of CD30-Expressing PTCL

An economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).


Amy Higginson, BS

Latest:

Evaluation of Collaborative Therapy Review to Improve Care of Heart Failure Patients

We implemented and evaluated a collaborative therapy review process aimed at optimizing heart failure therapy among patients managed by their primary care providers.


Patrick J. Roohan, MS

Latest:

Preventive Care for Chronically Ill Children in Medicaid Managed Care

The existence of chronic conditions did not adversely impact the ability of children in Medicaid managed care to access and utilize recommended preventive care services.


Dhwani Mehta, MS RD

Latest:

Two-Sided Risk in the Oncology Care Model

The US healthcare system remains one of the most inefficient healthcare systems in the world. The Bloomberg Health-Care Efficiency Index ranked the United States 54th among 56 countries in 2018, tied with Azerbaijan and only ahead of Bulgaria. This occurs even though the United States spends $10,244 per capita annually on healthcare, a figure representing 17% of the gross domestic product.


Robert S. Miller, MD, FACP, FASCO

Latest:

CancerLinQ - ASCO's Rapid Learning System to Improve Quality and Personalize Insights

CancerLinQ is a big data platform developed by the American Society of Clinical Oncology (ASCO) that aggregates clinical data from electronic health records for quality benchmarking and hypothesis generation. Such observational data can complement traditional evidence but must be used with caution.




Berhanu Alemayehu, DrPH, MS

Latest:

Costs Associated With Long-Acting Insulin Analogues in Patients With Diabetes

Findings from a literature review indicate that overall costs of long-acting insulin analogues are not significantly different from those of intermediate-acting human insulin and oral antidiabetic agents.


Margaret Shepherd, RPh, FAHM

Latest:

Collaborative DTM Reduces Hospitalization and Healthcare Costs in Patients With Diabetes Treated With Polypharmacy

Drug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.


Ateev Mehrotra, MD

Latest:

Paying for Telemedicine

With effective methods of promoting telemedicine yet to be established, new risk-based payment models offer the greatest potential for telemedicine's effective and efficient use.


Anil Aranha, PhD

Latest:

Health Literacy and Cardiovascular Disease Risk Factors Among the Elderly: A Study From a Patient-Centered Medical Home

A study to determine the health literacy of elderly patients and establish whether an association exists between health literacy and cardiovascular disease risk factors.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo